INTENSITY THERAPEUTICS, INC.
INTS$408M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSHELTON5 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
INTS News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply